Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
about
A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.Sleep disorders, obesity, and aging: the role of orexinTo ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance.Treatment of the sleep disorders associated with Parkinson's diseaseNocturnal journey of body and mind in Parkinson's disease: the manifestations, risk factors and their relationship to daytime symptoms. Evidence from the NIGHT-PD study.The hypocretin/orexin system: an increasingly important role in neuropsychiatry.Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease.Intranasal gene delivery for treating Parkinson's disease: overcoming the blood-brain barrier.Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders.RBD and Neurodegenerative Diseases.Reactivation of hyperglycemia-induced hypocretin (HCRT) gene silencing by N-acetyl-d-mannosamine in the orexin neurons derived from human iPS cells.Orexin-A increases the activity of globus pallidus neurons in both normal and parkinsonian rats.Sleep spindles, mobile phones, lucid dreaming and sleep in Parkinson's disease and autism spectrum disorders.Nesfatin-1 decreases excitability of dopaminergic neurons in the substantia nigra.Molecular Evolutionary Analysis of the HCRTR Gene Family in Vertebrates.Sleep Attacks in Patients With Parkinson's Disease on Dopaminergic Medications: A Systematic ReviewCharting the onset of Parkinson-like motor and non-motor symptoms in nonhuman primate model of Parkinson's disease
P2860
Q30240991-3739D8F0-11C1-4EF8-A7A3-B8AD49C8418AQ33587560-D68C4A45-3EF0-44B9-8346-90BAD0CB9476Q34451399-D8A77997-F0E2-4CF6-8056-5121F4C6E0BCQ34668388-66322A23-7222-40DC-B025-D683CCCC5E2FQ38165855-2B1CB61D-55F0-4BEB-95F2-B1744CE95C7CQ38200511-755B17BF-A243-49DB-99E3-59CEA89F6FDAQ38231949-77FE3DA2-0F11-4F55-AD5E-309DF2BFC5C9Q38271572-BB72C007-C706-46B1-BF36-5D064B55648BQ38569775-82D6C513-D73B-427A-B1D5-4C9C753897A9Q38687612-96E388B2-6D9E-40B3-9898-6216F51380CFQ38794700-7F430F8E-A1D4-4873-B6A4-F1DF4A34119CQ47305412-FDDB0846-D4E4-4391-A615-E59CD3536E7DQ48188354-180493EC-C506-43E2-8AB2-D689B2927C5CQ48209700-DBBE80B7-EF40-445A-AD86-829F97090551Q48876060-20E3B503-8C38-460F-A521-A6BB4DC0279AQ55405532-BBB288A4-854A-45FA-AA57-8BB80831BC02Q56441137-CF857E91-4AF5-4DDC-A94E-5A626432CC0FQ58715020-A2FEBE20-3ED5-4CF5-A422-D444337D03D3
P2860
Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Progressive dopamine and hypoc ...... pact on sleep and wakefulness?
@en
Progressive dopamine and hypoc ...... pact on sleep and wakefulness?
@nl
type
label
Progressive dopamine and hypoc ...... pact on sleep and wakefulness?
@en
Progressive dopamine and hypoc ...... pact on sleep and wakefulness?
@nl
prefLabel
Progressive dopamine and hypoc ...... pact on sleep and wakefulness?
@en
Progressive dopamine and hypoc ...... pact on sleep and wakefulness?
@nl
P2093
P2860
P1476
Progressive dopamine and hypoc ...... pact on sleep and wakefulness?
@en
P2093
Alexander Storch
Christian R Baumann
Claudio L Bassetti
Daniel Waldvogel
Heide Baumann-Vogel
Miriam Wienecke
Rositsa Poryazova
P2860
P304
P356
10.1111/J.1365-2869.2012.01027.X
P577
2012-07-02T00:00:00Z